Abstract
A new study published in the Journal of Clinical Oncology has ascertained the efficacy of selective serotonin-reuptake inhibitors, serotonin and norepinephrine reuptake inhibitors and gabapentin to decrease menopausal hot flashes. Are these nonhormonal treatment options a viable alternative to hormone replacement therapy?
MeSH terms
-
Adrenergic Uptake Inhibitors / adverse effects
-
Adrenergic Uptake Inhibitors / therapeutic use
-
Amines / adverse effects
-
Amines / therapeutic use*
-
Antidepressive Agents / therapeutic use*
-
Breast Neoplasms / drug therapy
-
Contraindications
-
Cyclohexanecarboxylic Acids / adverse effects
-
Cyclohexanecarboxylic Acids / therapeutic use*
-
Estrogen Replacement Therapy*
-
Female
-
Gabapentin
-
Hot Flashes / drug therapy*
-
Humans
-
Menopause*
-
Randomized Controlled Trials as Topic
-
Selective Serotonin Reuptake Inhibitors / adverse effects
-
Selective Serotonin Reuptake Inhibitors / therapeutic use
-
Tamoxifen / antagonists & inhibitors
-
gamma-Aminobutyric Acid / adverse effects
-
gamma-Aminobutyric Acid / therapeutic use*
Substances
-
Adrenergic Uptake Inhibitors
-
Amines
-
Antidepressive Agents
-
Cyclohexanecarboxylic Acids
-
Serotonin Uptake Inhibitors
-
Tamoxifen
-
gamma-Aminobutyric Acid
-
Gabapentin